
A DPD deficiency should be considered in case of severe toxicity even in the absence of common risk variants in DPYD.
Male, Antimetabolites, Antineoplastic, Dihydropyrimidine Dehydrogenase Deficiency/genetics, Dihydrouracil Dehydrogenase (NADP)/genetics, Dihydropyrimidine Dehydrogenase Deficiency, Antimetabolites, Capecitabine/adverse effects, Middle Aged, Antineoplastic/adverse effects, Fatal Outcome, Humans, Female, Capecitabine, Dihydrouracil Dehydrogenase (NADP)
Male, Antimetabolites, Antineoplastic, Dihydropyrimidine Dehydrogenase Deficiency/genetics, Dihydrouracil Dehydrogenase (NADP)/genetics, Dihydropyrimidine Dehydrogenase Deficiency, Antimetabolites, Capecitabine/adverse effects, Middle Aged, Antineoplastic/adverse effects, Fatal Outcome, Humans, Female, Capecitabine, Dihydrouracil Dehydrogenase (NADP)
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
